SEC Form 4 · accession 0001209191-17-039817
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey T. Walsh
Officer — Chief Financial · Other
Period of report
Jun 12, 2017
Accepted (ET)
Jun 14, 2017 · 4:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 12, 2017 | M | 2,500 | $2.0864 | A | 29,805 | D | |
| Common StockF2 | Jun 12, 2017 | S | 1,919 | $109.2645 | D | 27,886 | D | |
| Common StockF3 | Jun 12, 2017 | S | 579 | $110.4155 | D | 27,307 | D | |
| Common Stock | Jun 12, 2017 | S | 2 | $111.10 | D | 27,305 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4 | $2.0864 | Jun 12, 2017 | M | 2,500 | D | — | Jul 13, 2021 | Common Stock | 2,500 | 10,236 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2016.
- F2The range of prices for the transaction reported on this line was $108.90 to $109.75. The average weighted price was $109.2645. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The range of prices for the transaction reported on this line was $110.05 to $111.00. The average weighted price was $110.4155. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4This option vests over a four-year period, at a rate of twenty-five percent (25%) on May 16, 2012 and in 36 equal monthly installments thereafter.